Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts.
Hancock
W W
WW
Department of Nephrology, Prince Henry's Hospital, Melbourne, Victoria, Australia.
Sablinski
T
T
Milford
E L
EL
Tilney
N L
NL
Atkins
R C
RC
Kupiec-Weglinski
J W
JW
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000917:Antibody Formation; D015704:CD4 Antigens / Q000276:immunology*; D016207:Cytokines / Q000032:analysis; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007124:Immunoenzyme Techniques; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016038:Skin Transplantation / Q000276:immunology; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D016207:Cytokines